Sinopharm to produce up to one billion vaccine doses in Phase III trials
Sinopharm is establishing production lines for two COVID-19 vaccines undergoing Phase III trials involving 50,000 people across ten countries, including Egypt, Argentina, Jordan, and Peru.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan for full access to every Belfast Herald story and the complete archive.
NewsSinopharm to produce up to one billion vaccine doses in Phase III trials
Sign in or subscribeBrowse free archive reportsSinopharm is establishing production lines for two COVID-19 vaccines undergoing Phase III trials involving 50,000 people across ten countries, including Egypt, Argentina, Jordan, and Peru.